4-aminopyridine has been researched along with Autosomal Dominant Hereditary Spastic Paraplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selcuk Muhtaroglu, F | 1 |
| Belgen Kaygisiz, B | 1 |
| Usar Incirli, S | 1 |
| Kahraman, T | 1 |
| Béreau, M | 1 |
| Anheim, M | 1 |
| Chanson, JB | 1 |
| Tio, G | 1 |
| Echaniz-Laguna, A | 1 |
| Depienne, C | 1 |
| Collongues, N | 1 |
| de Sèze, J | 1 |
1 trial available for 4-aminopyridine and Autosomal Dominant Hereditary Spastic Paraplegia
| Article | Year |
|---|---|
Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial.
Topics: 4-Aminopyridine; Humans; Muscle Spasticity; Pilot Projects; Spastic Paraplegia, Hereditary; Walking | 2023 |
1 other study available for 4-aminopyridine and Autosomal Dominant Hereditary Spastic Paraplegia
| Article | Year |
|---|---|
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
Topics: 4-Aminopyridine; Adult; Aged; Alkaloids; Analysis of Variance; Female; Follow-Up Studies; Humans; Ma | 2015 |